Avalon Globocare (ALBT)

$0.41 +0.00 (0.54%)
Market Cap 3.39M
Revenue (ttm) 0.00
Net Income (ttm) -18.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -1.01
Volume 335,500
Avg Vol 8,934,951
Day's Range N/A - N/A
Shares Out 8.32M
Stochastic %K 40%
Beta 0.10
Analysts Strong Buy
Price Target N/A

Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.

Industry: Real Estate Services
Sector: Real Estate
Phone: 732 780 4400
Address:
4400 Route 9 South, Suite 3100, Freehold, United States
AvalonGloboCareIR
AvalonGloboCareIR Apr. 27 at 6:18 PM
$ALBT With Phase 2 underway, Avalon is entering a more defined stage in the development of its AI-driven video platform. The current focus is execution. Advancing agentic capabilities, strengthening system architecture, and moving toward a more deployable framework over the coming months. The collaboration with Amazon Web Services and Caylent provides the infrastructure and technical foundation to support this transition, aligning development with scalability and real-world application. It also enhances its ability to scale as it advances broader adoption and long-term monetization.
0 · Reply
juanpa9210
juanpa9210 Apr. 27 at 12:37 PM
$ALBT
0 · Reply
unfrh567
unfrh567 Apr. 26 at 2:13 PM
$ALBT projected four months to a more deployable version is interesting...hope the collaboration helps them move faster toward something real.
0 · Reply
AvalonGloboCareIR
AvalonGloboCareIR Apr. 24 at 1:47 PM
$ALBT Avalon is moving into the next phase of its AI-driven video platform, building on its collaboration with Amazon Web Services and Caylent. The focus is on agentic systems. Not static AI, but models capable of interpreting inputs, adapting in real time, and executing tasks across complex environments with reduced human intervention. Development is progressing through Phase 2, with a projected timeline of four months to enhance capabilities and move toward a more deployable framework. AWS provides a scalable infrastructure. Caylent supports the architecture and buildout. Together, this collaboration is expected to accelerate Phase 2 of our Catch-Up SaaS platform and advance its evolution into a fully autonomous, agentic AI solution with expanded capabilities and market reach.
0 · Reply
AvalonGloboCareIR
AvalonGloboCareIR Apr. 23 at 2:31 PM
$ALBT Thank you for highlighting several aspects of the Company’s recent developments. Avalon has been advancing its AI-focused strategy through Avalon Quantum AI, including continued progress on its Catch-Up platform and related infrastructure initiatives. Recent steps, such as working with experienced cloud and development partners, are intended to support scalability and ongoing platform development as these systems evolve.
1 · Reply
DrHouse80
DrHouse80 Apr. 22 at 3:36 PM
$ALBT this is algo trading... its ok. Its broken a powerful resistance now holding steadily
0 · Reply
DrHouse80
DrHouse80 Apr. 22 at 3:30 PM
$ALBT this is algo trading... its ok. Its broken absolod resistance now holding steadily
0 · Reply
DrHouse80
DrHouse80 Apr. 22 at 3:26 PM
$ALBT this is algo trading... its ok. Its broken absolod resistance now holding steadily
0 · Reply
juanpa9210
juanpa9210 Apr. 22 at 3:08 PM
$ALBT feels like its going to explode at anytime!
0 · Reply
AvalonGloboCareIR
AvalonGloboCareIR Apr. 22 at 3:03 PM
$ALBT Avalon has taken a step forward in the evolution of its AI platform. Through its collaboration with AWS and Caylent, the company is advancing the next phase of its AI-driven video technology, focused on agentic and autonomous capabilities. The initiative is supported by a conditional grant of up to $125,000, reinforcing both the technical direction and the external validation behind the platform. This marks a transition into a more defined execution phase, with development milestones now aligned over the coming months. As the Company advances this platform, the combination of external validation, defined execution milestones, and expanded accessibility enhance its ability to execute on its growth objectives.
1 · Reply
Latest News on ALBT
Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development

Apr 21, 2026, 8:30 AM EDT - 7 days ago

Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development

Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 27, 2026, 5:30 PM EST - 2 months ago

Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2026, 9:20 PM EST - 2 months ago

Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Avalon GloboCare (ALBT) Stock Surges On AMD AI News

Feb 26, 2026, 10:09 AM EST - 2 months ago

Avalon GloboCare (ALBT) Stock Surges On AMD AI News

AMD

Top 3 Real Estate Stocks Which Could Rescue Your Portfolio This Month

Jan 27, 2026, 8:01 AM EST - 3 months ago

Top 3 Real Estate Stocks Which Could Rescue Your Portfolio This Month

DEI HPP

FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer

Jan 21, 2026, 9:35 AM EST - 3 months ago

FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer

Avalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video Platform

Jan 12, 2026, 9:00 AM EST - 3 months ago

Avalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video Platform

Avalon GloboCare Board Director Highlights RPM Interactive's Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com

Dec 30, 2025, 9:00 AM EST - 4 months ago

Avalon GloboCare Board Director Highlights RPM Interactive's Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com

E.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCare

Dec 23, 2025, 10:00 AM EST - 4 months ago

E.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCare

Myseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare Acquisition

Dec 15, 2025, 8:32 AM EST - 4 months ago

Myseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare Acquisition

MYSE

Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction

Dec 15, 2025, 8:30 AM EST - 4 months ago

Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

Dec 1, 2025, 9:00 AM EST - 5 months ago

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom

Aug 28, 2025, 9:00 AM EDT - 8 months ago

Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom

Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders

Jul 28, 2025, 9:00 AM EDT - 9 months ago

Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders

Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong

Jul 14, 2025, 8:00 AM EDT - 10 months ago

Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong

Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Jun 26, 2025, 8:00 AM EDT - 10 months ago

Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Top 2 Real Estate Stocks Which Could Rescue Your Portfolio This Quarter

Jun 17, 2025, 6:22 AM EDT - 11 months ago

Top 2 Real Estate Stocks Which Could Rescue Your Portfolio This Quarter

MKZR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN and ALBT on Behalf of Shareholders

Mar 12, 2025, 7:15 PM EDT - 1 year ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN and ALBT on Behalf of Shareholders

JWN

Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device

Nov 18, 2024, 9:00 AM EST - 1 year ago

Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device

Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction

Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report

May 24, 2024, 5:00 PM EDT - 2 years ago

Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report

Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference

Apr 22, 2024, 9:00 AM EDT - 2 years ago

Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference

Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union

Mar 28, 2024, 9:00 AM EDT - 2 years ago

Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union

Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US

Dec 18, 2023, 9:00 AM EST - 2 years ago

Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US

Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application

Oct 4, 2023, 9:00 AM EDT - 2 years ago

Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application

Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device

Sep 13, 2023, 9:15 AM EDT - 2 years ago

Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device

Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis

Aug 30, 2023, 9:00 AM EDT - 2 years ago

Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis

Avalon's Laboratory Services MSO Announces Expansion into Arizona

Aug 21, 2023, 9:00 AM EDT - 2 years ago

Avalon's Laboratory Services MSO Announces Expansion into Arizona

Avalon's Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

Jul 24, 2023, 9:00 AM EDT - 3 years ago

Avalon's Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

Avalon GloboCare's Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

Jul 19, 2023, 9:00 AM EDT - 3 years ago

Avalon GloboCare's Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

Avalon GloboCare Provides Update on New Commercial Strategy

Jul 10, 2023, 9:00 AM EDT - 3 years ago

Avalon GloboCare Provides Update on New Commercial Strategy

Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022

Apr 27, 2023, 9:00 AM EDT - 3 years ago

Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022

Avalon GloboCare to Participate in the 35th Annual Roth Conference

Mar 3, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare to Participate in the 35th Annual Roth Conference

Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company

Feb 13, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company

Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules

Jan 17, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules

Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors

Jan 11, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors

Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology

Jan 3, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology

Avalon GloboCare Announces $4 Million Private Placement of Preferred Stock with the Company's Chairman which Converts at a Significant Premium to Market; Proceeds to Support Acquisition of Laboratory Services

Dec 14, 2022, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces $4 Million Private Placement of Preferred Stock with the Company's Chairman which Converts at a Significant Premium to Market; Proceeds to Support Acquisition of Laboratory Services

Avalon GloboCare Continues its U.S. Centric Strategy with a New Proposed Board Composition in Preparation for Acquisition of Laboratory Services MSO, LLC

Dec 12, 2022, 9:00 AM EST - 3 years ago

Avalon GloboCare Continues its U.S. Centric Strategy with a New Proposed Board Composition in Preparation for Acquisition of Laboratory Services MSO, LLC

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”

Nov 9, 2022, 4:00 PM EST - 3 years ago

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”

AvalonGloboCareIR
AvalonGloboCareIR Apr. 27 at 6:18 PM
$ALBT With Phase 2 underway, Avalon is entering a more defined stage in the development of its AI-driven video platform. The current focus is execution. Advancing agentic capabilities, strengthening system architecture, and moving toward a more deployable framework over the coming months. The collaboration with Amazon Web Services and Caylent provides the infrastructure and technical foundation to support this transition, aligning development with scalability and real-world application. It also enhances its ability to scale as it advances broader adoption and long-term monetization.
0 · Reply
juanpa9210
juanpa9210 Apr. 27 at 12:37 PM
$ALBT
0 · Reply
unfrh567
unfrh567 Apr. 26 at 2:13 PM
$ALBT projected four months to a more deployable version is interesting...hope the collaboration helps them move faster toward something real.
0 · Reply
AvalonGloboCareIR
AvalonGloboCareIR Apr. 24 at 1:47 PM
$ALBT Avalon is moving into the next phase of its AI-driven video platform, building on its collaboration with Amazon Web Services and Caylent. The focus is on agentic systems. Not static AI, but models capable of interpreting inputs, adapting in real time, and executing tasks across complex environments with reduced human intervention. Development is progressing through Phase 2, with a projected timeline of four months to enhance capabilities and move toward a more deployable framework. AWS provides a scalable infrastructure. Caylent supports the architecture and buildout. Together, this collaboration is expected to accelerate Phase 2 of our Catch-Up SaaS platform and advance its evolution into a fully autonomous, agentic AI solution with expanded capabilities and market reach.
0 · Reply
AvalonGloboCareIR
AvalonGloboCareIR Apr. 23 at 2:31 PM
$ALBT Thank you for highlighting several aspects of the Company’s recent developments. Avalon has been advancing its AI-focused strategy through Avalon Quantum AI, including continued progress on its Catch-Up platform and related infrastructure initiatives. Recent steps, such as working with experienced cloud and development partners, are intended to support scalability and ongoing platform development as these systems evolve.
1 · Reply
DrHouse80
DrHouse80 Apr. 22 at 3:36 PM
$ALBT this is algo trading... its ok. Its broken a powerful resistance now holding steadily
0 · Reply
DrHouse80
DrHouse80 Apr. 22 at 3:30 PM
$ALBT this is algo trading... its ok. Its broken absolod resistance now holding steadily
0 · Reply
DrHouse80
DrHouse80 Apr. 22 at 3:26 PM
$ALBT this is algo trading... its ok. Its broken absolod resistance now holding steadily
0 · Reply
juanpa9210
juanpa9210 Apr. 22 at 3:08 PM
$ALBT feels like its going to explode at anytime!
0 · Reply
AvalonGloboCareIR
AvalonGloboCareIR Apr. 22 at 3:03 PM
$ALBT Avalon has taken a step forward in the evolution of its AI platform. Through its collaboration with AWS and Caylent, the company is advancing the next phase of its AI-driven video technology, focused on agentic and autonomous capabilities. The initiative is supported by a conditional grant of up to $125,000, reinforcing both the technical direction and the external validation behind the platform. This marks a transition into a more defined execution phase, with development milestones now aligned over the coming months. As the Company advances this platform, the combination of external validation, defined execution milestones, and expanded accessibility enhance its ability to execute on its growth objectives.
1 · Reply
Dickman777
Dickman777 Apr. 22 at 2:03 PM
$ALBT shouldn’t be under .50 let alone .70 no brainer buys all morning here!!
1 · Reply
Klinsmann
Klinsmann Apr. 22 at 1:52 PM
$ALBT just add and hold. Unreal overreaction ob good news yesterday
0 · Reply
Lrod0175
Lrod0175 Apr. 22 at 1:42 PM
$ALBT let's get this back to $.50 not much resistance on lvl 2, imo.
0 · Reply
traderkiww
traderkiww Apr. 22 at 11:58 AM
$ALBT Is this going back to.45s today? I have 0.43 average
1 · Reply
traderkiww
traderkiww Apr. 22 at 8:41 AM
$ALBT no vol .. 😞
0 · Reply
traderkiww
traderkiww Apr. 21 at 10:22 PM
$ALBT No runup happening..maybe tomorrow?
0 · Reply
traderkiww
traderkiww Apr. 21 at 10:21 PM
$ALBT thought ALBT would be .60 at least today, what do u think so for tomorrow? Woulda been nice if it did a LOBO run today or tomorrow lol
0 · Reply
Dickman777
Dickman777 Apr. 21 at 10:14 PM
$LOBO round 2 starting $$ALBT how is this under .50
1 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Apr. 21 at 8:35 PM
$ALBT but for sure has bullish news for a next-day climb
0 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Apr. 21 at 8:35 PM
$ALBT I lost $400 off news but better to sell quick than lose thousands haha
1 · Reply
DrHouse80
DrHouse80 Apr. 21 at 7:57 PM
$ALBT in
0 · Reply
MrTicker
MrTicker Apr. 21 at 7:50 PM
$ALBT news is solid. Could see a run up after hours
1 · Reply